Home > Financial Ratios > JUBILANT PHARMOVA

JUBILANT PHARMOVA
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for JUBILANT PHARMOVA
Please provide your vote to see the results

JUBILANT PHARMOVA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 19.03-30.24-17.43-10.80-10.67

What is the latest Core EBITDA Growth ratio of JUBILANT PHARMOVA ?

The latest Core EBITDA Growth ratio of JUBILANT PHARMOVA is 19.03 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202419.03
Mar2023-30.24
Mar2022-17.43
Mar2021-10.80
Mar2020-10.67

How is Core EBITDA Growth of JUBILANT PHARMOVA Trending?

Years Core EBITDA Growth % Change
Mar2024 19.03
Positive
Mar2023 -30.24
Negative
Mar2022 -17.43
Negative
Mar2021 -10.8
Negative
Mar2020 -10.67 -

Other Financial Ratios of JUBILANT PHARMOVA


Compare Core EBITDA Growth ratio of peers of JUBILANT PHARMOVA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JUBILANT PHARMOVA ₹13,906.9 Cr -2.6% -4.5% 35% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹436,379.0 Cr 0.8% 7.2% 22.2% Stock Analytics
DIVIS LABORATORIES ₹163,420.0 Cr 0.7% 11% 53.3% Stock Analytics
CIPLA ₹122,010.0 Cr -2% 4.6% 10.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,634.0 Cr -1.6% 2.8% 24.4% Stock Analytics
DR REDDYS LABORATORIES ₹96,788.5 Cr -1.4% 0.7% -5.5% Stock Analytics


JUBILANT PHARMOVA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JUBILANT PHARMOVA

-2.6%

-4.5%

35%

SENSEX

0.5%

4.2%

8%


You may also like the below Video Courses